Health
Moderna Skin Cancer Vaccine Prevents Melanoma Return
Moderna and Merck report that their personalised mRNA skin cancer vaccine Intismeran stopped melanoma from returning in a major phase three trial.
Bringing you stories that vibe with your fashion